Table 1.
Baseline characteristics
| Observed parameter | All | ICA (± MCA) occlusion | MCA occlusion |
|---|---|---|---|
| Patients, n (%) | 110 (100) | 37 (33.6) | 73 (66.4) |
|
| |||
| Age (years), mean±SD | 73.0±11.5 (38–93) | 70.1±11.6 (43–88) | 74.4±11.3 (38–93) |
| >80 years, n (%) | 33 (30) | 9 (24.3) | 24 (32.9) |
|
| |||
| Male sex, n (%) | 44 (40) | 17 (15.5) | 27 (24.5) |
|
| |||
| Vascular risk factors, n(%) | |||
| Arterial hypertension | 86 (78.2) | 29 (26.4) | 57 (51.8) |
| Diabetes mellitus | 34 (30.9) | 11 (10) | 23 (20.9) |
| Dyslipidemia | 35 (31.8) | 9 (8.2) | 23 (20.9) |
| Atrial fibrillation | 58 (52.7) | 12 (10.9) | 46 (41.8) |
| Ischemic heart disease | 25 (22.7) | 10 (9.1) | 15 (13.6) |
|
| |||
| NIHSS baseline, median (range) | 14.5 (5–40) | 14.0 (5–25) | 15.0 (5–40) |
|
| |||
| Onset-to-groin puncture time (min), median (range) | 245.5 (35–1220) | 246.0 (105–1220) | 245.0 (35–1150) |
|
| |||
| Recanalization methods | |||
|
| |||
| Stent retrievers, n (%) | 104 (94.5) | 32 (86.5) | 72 (98.6) |
| Stent retriever type, n of devices | 108 | ||
| Solitaire | 87 | ||
| Trevo | 16 | ||
| Eric 4 | 2 | ||
| Catch | 1 | ||
| Preset | 2 | ||
|
| |||
| i. a. Actilyse (± stent retriever), n (%) | 3 (2.7) | 0 (0) | 3 (4.1) |
|
| |||
| Intracranial PTAS, n (%) | 2 (1.8) | 1 (0.9) | 1 (0.9) |
|
| |||
| CAS, n (%) | 18 (16.4) | 18 (48.6) | 0 (0) |
|
| |||
| IVT, n (%) | 69 (62.7) | 24 (64.9) | 45 (61.6) |
ICA, internal carotid artery; MCA, middle cerebral artery; SD, standard deviation; NIHSS, National Institutes of Health Stroke Scale; Solitaire, Solitaire™, Covidien; Trevo, Trevo® ProVue™, Concentric Medical; Eric 4, ERIC® 4 Retrieval Device, MicroVention Terumo Medical; Catch, Catch Device®, Balt Extrusion; Preset, pREset®, Phenox GmbH; rtPA, recombinant tissue plasminogen activator; PTAS, percutaneous transluminal angioplasty with stent placement; CAS, carotid stenting; IVT, intravenous thrombolysis.